Case Consult: Optimizing the Management of cTTP by Faculty / Presenters
ISTH Academy; Presenters F. Nov 19 2024; 4147458;
Related Articles
Reversing the side effects of immunotherapy
Immunotherapy is curing many cancers, but when immunotherapy triggers autoimmune and other side effects, a unique clinic @OSUCCC_James is giving patients relief.
The Latino Realignment Looks Real. But It May Not Be Permanent.
Digging deep into the data shows why so many Latino voters abandoned Democrats.
Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome – PubMed
A combination of immunological reaction to a drug and HHV-6 reactivation results in the severe course of DIHS. The demonstration of HHV-6 reactivation is a…
Impact of Screening on Mortality for Patients Diagnosed with Hepatocellular Carcinoma in a Safety-Net Healthcare System: An Opportunity for Addressing Disparities
Purpose: We describe the impact of screening on outcomes of patients diagnosed with hepatocellular carcinoma (HCC) in an urban safety-net healthcare system compared to a…
A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis
Key PointsThe overall response rate for low-dose subcutaneous decitabine was 33% in this prospective clinical trial of 21 patients with myelofibrosis.A hig
Epigenetic Modifications: New Therapeutic Targets in Primary Myelofibrosis
Primary Myelofibrosis previously also known as Agnogenic Myeloid Metaplasia or Idiopathic Myelofibrosis is a complex myeloproliferative disease. Although the initial genetic insult that causes uncontrolled…